Results

Total Results: 430 records

Showing results for "cardiac".
Users also searched for: ekg

  1. effectivehealthcare.ahrq.gov/health-topics/rehabilitation
  2. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
    July 01, 2013 - Among 2472 patients evaluated at 1 year and 1127 evaluated at 2 years, the rate of cardiac 17 … cardiovascular outcomes trial (CVOT) to assess the effects of the drug on the risk of major adverse cardiac … fenfluramine and dexfenfluramine), were withdrawn from the market because of their association with cardiac … fenfluramine and dexfenfluramine, were withdrawn from the market because of their association with cardiac … However, data from at least one study suggests lorcaserin may not increase cardiac valvular disease
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - as a proxy the average cost of new and novel cardiac valves or devices that entered the U.S. market … presenting cardiology research X X X X X X X 36 European Society of Cardiology’s (ESC) Acute Cardiac … Care 1, 11 Annual meeting presenting research on treatments of acute cardiac conditions X X X … X X X X 37 Heart Rhythm Society (HRS) 1, 11 Annual meeting presenting research on cardiac rhythm … Society for Cardiovascular Angiography and Interventions (SCAI) 1, 11 Annual meeting covering cardiac
  4. effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - as a proxy the average cost of new and novel cardiac valves or devices that entered the U.S. market … presenting cardiology research X X X X X X X 36 European Society of Cardiology’s (ESC) Acute Cardiac … Care 1, 11 Annual meeting presenting research on treatments of acute cardiac conditions X X X … X X X X 37 Heart Rhythm Society (HRS) 1, 11 Annual meeting presenting research on cardiac rhythm … Society for Cardiovascular Angiography and Interventions (SCAI) 1, 11 Annual meeting covering cardiac
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
    August 01, 2012 - the help of an eight-person Key Informant group representing clinicians (cardiology, primary care, cardiac … Literature flow diagram 19 baseline clinical characteristics (e.g., age, diabetes, sex, individual cardiac … clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac … there a gender difference in risk profile, attendance, and beneficial effects of a multidisciplinary cardiacCardiac syndrome X. In: Wenger NK and Collins P, eds. Women and heart disease. 2nd ed.
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - enzyme.13 This enzyme is involved in the oxidative metabolism of many synthetic drugs,14-20 including cardiac … how the review will differentiate between varying effects of drug-supplement combinations, as most cardiac … Herbal therapies and cardiac side effects. Prog Cardiovasc Nurs 2008;23:187-90. 17.
  7. effectivehealthcare.ahrq.gov/health-topics/electrical-injuries
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
    January 01, 2022 - treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 (95% CI 0.47 to 0.77) Cardiac
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
    January 01, 2022 - treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 (95% CI 0.47 to 0.77) Cardiac
  10. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol-amendment.pdf
    February 02, 2022 - factors (hypertension, diabetes, hyperlipidemia, tobacco use, obesity, physical inactivity) ● Cardiac … Near-miss maternal mortality: cardiac dysfunction as the principal cause of obstetric intensive care
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
    January 01, 2014 - presence of either ST segment depression or T-wave inversion on electrocardiography and/or abnormal cardiac … NSTEMI is broadly classified as upstream if the therapy is initiated after admission but prior to cardiac … consists of an oral antiplatelet agent or intravenous (IV) GPI as initial therapy prior to going to the cardiac … Intravenous GPI (select one) – Eptifibatide – Tirofiban – Abciximab Cardiac … , with greater use of conservative, medically managed approaches in countries with less access to cardiac
  12. effectivehealthcare.ahrq.gov/products/acs-pci-adjunctive-devices/research-protocol
  13. effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
    January 01, 2018 - Tricyclic Antidepressants - Placebo-Controlled Trials WAE WAE SAE SAE Cardiac Rhythm Abnormalities … Cardiac Rhythm Abnormalities Cardiac Rhythm Abnormalities Cardiac Rhythm Abnormalities Cognitive Effects
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_disposition-comments.pdf
    August 16, 2016 - 3 indications for renal intervention: 1 renovascular hypertension; 2 ischemic nephropathy; and 3 cardiac … improvement in uncontrolled HTN, preservation or salvage of kidney function, prevention or treatment of cardiac … or severity of CHF following medical or interventional therapy for RAS in patients with unstable cardiac
  15. MEDLINE Searches (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
    March 01, 2009 - Favorable cardiac risk among elderly breast carcinoma survivors. Cancer 2003;98(1):2-10. … Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised … Comparison of the effects of tibolone and estrogen replacement therapy on echocardiographic basic cardiac … Rate Veronesi, 200729: 21 2.01 35 3.48 1.73 1.01-2.98 Cardiac Arrhythmias, Atrial Fibrillation … 64 2.37 1.15 0.81-1.64 Checklist of predefined side effects asked directly during main trial All cardiac
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/binge-eating_clinician.pdf
    May 01, 2016 - Avoid use in patients with known structural cardiac abnormalities, cardiomyopathy, serious heart arrhythmia
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
    February 01, 2011 - diabetes are expected to suffer from several associ- ated medical complications, such as renal disease, cardiac
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
    May 01, 2024 - center China Intervention: 1,757 Control: 530 Active surveillance of all patients undergoing cardiac … of preoperative Staphylococcus aureus screening and targeted decolonization bundle protocols in cardiac … 202219 Retrospecti ve cohort Examine the prevalence of MRSA colonization in patients prior to cardiac … Shanghai Jiao Tong University School of Medicine Active surveillance of all patients undergoing cardiac
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
    July 01, 2023 - The New York State cardiac registries: history, contributions, limitations, and lessons for future efforts
  20. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_executive.pdf
    October 01, 2007 - The demographic characteristics and cardiac risk factor profiles of trial participants were typical of … left main or left main equivalent disease randomized to PCI supported by retroinfusion of the anterior cardiac

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: